Scholarlink

Background <p>Chronic hepatitis B (CHB) in children poses a significant public health challenge, yet data on the prevalence of significant liver lesions in this group are limited.</p> Methods <p>A comprehensive meta-analysis pooled data on the proportion of significant liver lesions among CHB children. Using the double arcsine transformation and a random-effects model, we combined data on moderate to severe liver inflammation, fibrosis, and cirrhosis. Subgroup analysis and meta-regression were conducted to explore heterogeneity.</p> Results <p>Twenty-two studies with 3,037 participants were included. The proportion of moderate to severe inflammation was 41.54% [95% Confidence Interval (CI): 29.14–54.47%], notable fibrosis was 31.71% [95% CI: 23.85–40.11%], and cirrhosis was 2.27% [95% CI: 1.06–3.82%]. Inflammation varied significantly by age group: &lt; 6&#xa0;years, 36.21%; 6–12&#xa0;years, 53.72%; 12–18&#xa0;years, 31.40% (<i>p</i> &lt; 0.01). ALT ≥ 80 U/L was associated with higher inflammation (57.78%) compared to ALT &lt; 80 U/L (29.73%) (<i>p</i> &lt; 0.01). Cirrhosis also varied significantly by age group.</p> Conclusions <p>A substantial proportion of CHB children have significant liver lesions, underscoring the need for enhanced screening and monitoring.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Significant histologic alterations in untreated chronic hepatitis B children: a meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月13日

查看全文
  • Chenyang Huang,
  • Xin Guo,
  • Ziwei Wang,
  • Yuefei Pan,
  • Qiyu Jiang,
  • Jing Li,
  • Peiyao Fan,
  • Junliang Fu,
  • Min Zhang,
  • Fu-Sheng Wang

摘要

Background

Chronic hepatitis B (CHB) in children poses a significant public health challenge, yet data on the prevalence of significant liver lesions in this group are limited.

Methods

A comprehensive meta-analysis pooled data on the proportion of significant liver lesions among CHB children. Using the double arcsine transformation and a random-effects model, we combined data on moderate to severe liver inflammation, fibrosis, and cirrhosis. Subgroup analysis and meta-regression were conducted to explore heterogeneity.

Results

Twenty-two studies with 3,037 participants were included. The proportion of moderate to severe inflammation was 41.54% [95% Confidence Interval (CI): 29.14–54.47%], notable fibrosis was 31.71% [95% CI: 23.85–40.11%], and cirrhosis was 2.27% [95% CI: 1.06–3.82%]. Inflammation varied significantly by age group: < 6 years, 36.21%; 6–12 years, 53.72%; 12–18 years, 31.40% (p < 0.01). ALT ≥ 80 U/L was associated with higher inflammation (57.78%) compared to ALT < 80 U/L (29.73%) (p < 0.01). Cirrhosis also varied significantly by age group.

Conclusions

A substantial proportion of CHB children have significant liver lesions, underscoring the need for enhanced screening and monitoring.